Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Depreciation and Depletion (2016 - 2024)

Northwest Biotherapeutics' Depreciation and Depletion history spans 10 years, with the latest figure at $500000.0 for Q2 2024.

  • Quarterly results put Depreciation and Depletion at $500000.0 for Q2 2024, up 25.0% from a year ago — trailing twelve months through Jun 2024 was $1.7 million (up 21.43% YoY), and the annual figure for FY2025 was $1.9 million, up 11.76%.
  • Depreciation and Depletion for Q2 2024 was $500000.0 at Northwest Biotherapeutics, up from $400000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $500000.0 in Q2 2022 to a low of $2000.0 in Q2 2020.
  • The 4-year median for Depreciation and Depletion is $350000.0 (2022), against an average of $270500.0.
  • Peak annual rise in Depreciation and Depletion hit 980.0% in 2020, while the deepest fall reached 66.67% in 2020.
  • Year by year, Depreciation and Depletion stood at $54000.0 in 2020, then soared by 640.74% to $400000.0 in 2022, then changed by 0.0% to $400000.0 in 2023, then grew by 25.0% to $500000.0 in 2024.
  • According to Business Quant data, Depreciation and Depletion over the past three periods came in at $500000.0, $400000.0, and $400000.0 for Q2 2024, Q1 2024, and Q4 2023 respectively.